10 studies found for:    Open Studies | "Norovirus"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Norovirus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)
Condition: Gastroenteritis Norovirus
Interventions: Biological: Norovirus GII.4 Challenge Pool CIN-1;   Other: Placebo
2 Not yet recruiting Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis Norovirus
Interventions: Biological: Snow Mountain stool filtrate;   Other: Placebo
3 Recruiting Human Breastmilk in Young Children With Norovirus Infection of the Gut
Condition: Norovirus
Intervention: Biological: Donor Breastmilk
4 Not yet recruiting Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine in Children
Condition: Norovirus
Interventions: Biological: GI.1/GII.4 (15/15) - MPL (50);   Biological: GI.1/GII.4 (15/50) - MPL (50);   Biological: GI.1/GII.4 (50/50) - MPL (50);   Biological: GI.1/GII.4 (15/15) - MPL (15);   Biological: GI.1/GII.4 (15/50) - MPL (15);   Biological: GI.1/GII.4 (50/50) - MPL (15);   Biological: GI.1/GII.4 (15/15);   Biological: GI.1/GII.4 (15/50);   Biological: GI.1/GII.4 (50/50);   Biological: GI.1/GII.4 (50/150);   Biological: GI.1/GII.4 (15/50) - Al(OH)3 (167);   Drug: Placebo
5 Recruiting Secondary Lactose Intolerance Due to Chronic Norovirus Infection
Condition: Chronic Diarrhea
Intervention: Behavioral: Lactose H2 breath test (LH2BT)
6 Recruiting A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Condition: Acute Gastroenteritis
Intervention:
7 Not yet recruiting NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
Condition: Advanced Refractory Solid Tumors
Intervention: Drug: NOV120401
8 Recruiting LCI-NEU-NOV-001: A Phase II Study of NovoTTF-100A in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM
Condition: Cancer of Brain and Nervous System
Intervention: Device: bevacizumab, NovoTTF100A, temozolomide
9 Recruiting Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
Condition: Metastatic Breast Cancer
Intervention: Drug: NOV120101 (Poziotinib)
10 Recruiting Viral Infections in Healthy and Immunocompromised Hosts
Condition: Herpes Viruses
Intervention:

Indicates status has not been verified in more than two years